Obinutuzumab in the Management of Idiopathic Membranous Nephropathy

Clinical trial NCT05845762 · UNKNOWN

Trial details

NCT number: NCT05845762
Sponsor: Qianfoshan Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Idiopathic Membranous Nephropathy

Start date: 2023-07-01
Primary completion: 2023-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.